- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Evolent Health Inc (EVH)
Evolent Health Inc stock price live, this page displays NYSE EVH stock exchange data. View the EVH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Evolent Health Inc real time stock price chart below.
What Is the Evolent Health Inc Stock Price Today?
The Evolent Health Inc stock price today is 10.82.
What Is the Stock Symbol for Evolent Health Inc?
The stock symbol for Evolent Health Inc is "EVH."
What Stock Exchange Does Evolent Health Inc Trade On?
Evolent Health Inc is listed and trades on the NYSE stock exchange.
Is Evolent Health Inc a Good Stock to Buy?
Determining whether Evolent Health Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EVH quote. (ISIN: US30050B1017)
What Is the Evolent Health Inc Stock Price Today?
The Evolent Health Inc stock price today is 10.82.
What Is the Stock Symbol for Evolent Health Inc?
The stock symbol for Evolent Health Inc is "EVH."
What Stock Exchange Does Evolent Health Inc Trade On?
Evolent Health Inc is listed and trades on the NYSE stock exchange.
Is Evolent Health Inc a Good Stock to Buy?
Determining whether Evolent Health Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EVH quote. (ISIN: US30050B1017)
10.82
-0.36(-3.22%)
Real-time Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.82
11.49
52 wk Range
10.53
35.00
EVH Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.8211.49
52 wk Range
10.5335.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EVH Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
23.15
Upside
+113.93%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
- KeyBanc optimistic on EVH stock following updates
- Investing.com
- KeyBanc optimistic on EVH stock following updates
- Investing.com
Evolent Health Inc Company Profile
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Evolent Health Inc SWOT Analysis
Revenue Surge | Evolent Health reports impressive 37.9% year-over-year revenue growth, showcasing strong market demand for its healthcare technology solutions |
Strategic Acquisitions | Explore how Evolent's Machinify acquisition enhances AI-driven efficiencies, potentially leading to significant cost savings and improved margins |
Market Challenges | Delve into Evolent's navigation of Medicaid redeterminations and elevated medical costs, and their potential impact on the company's financial outlook |
Analyst Optimism | Learn about the bullish analyst consensus, with price targets ranging from $31 to $45, suggesting significant upside potential for Evolent Health |
Evolent Health Inc Earnings Call Summary for Q2/2024
- Q2 revenue exceeded expectations; full-year guidance raised to $2.56-$2.6B with adjusted EBITDA of $230-245M
- Acquired Machinify Technology to enhance efficiency and product offerings; four new revenue agreements adding $70M+ in bookings
- New rate agreements to add ~$60M in annualized revenue, with benefits starting Q3 2024
- On track for $300M adjusted EBITDA run rate by end of 2024; cash flow from operations expected to exceed $150M for the year
- Q3 projections: $615-635M revenue, $60-68M adjusted EBITDA; costs remain elevated but partially offset by rate increases
Last Updated: 2024-08-09, 01:44 p/m
Read Full TranscriptCompare EVH to Peers and Sector
Metrics to compare | EVH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEVHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.5x | −1.3x | −0.6x | |
PEG Ratio | −1.01 | 0.01 | 0.00 | |
Price/Book | 1.3x | 1.3x | 2.6x | |
Price / LTM Sales | 0.5x | 1.3x | 3.1x | |
Upside (Analyst Target) | 75.1% | 24.1% | 55.2% | |
Fair Value Upside | Unlock | 32.0% | 9.8% | Unlock |
Analyst Ratings
14 Buy
1 Hold
0 Sell
Ratings:
15 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 23.15
(+113.93% Upside)
Earnings
Latest Release
Nov 7, 2024
EPS / Forecast
0.04 / 0.28
Revenue / Forecast
621.40M / 627.17M
People Also Watch
FAQ
What Is the Evolent Health Inc (EVH) Stock Price Today?
The Evolent Health Inc stock price today is 10.82
What Stock Exchange Does Evolent Health Inc Trade On?
Evolent Health Inc is listed and trades on the NYSE stock exchange.
What Is the Stock Symbol for Evolent Health Inc?
The stock symbol for Evolent Health Inc is "EVH."
What Is the Evolent Health Inc Market Cap?
As of today, Evolent Health Inc market cap is 1.27B.
What is Evolent Health Inc Earnings Per Share?
The Evolent Health Inc EPS is -0.912.
What Is the Next Evolent Health Inc Earnings Date?
Evolent Health Inc will release its next earnings report on Feb 19, 2025.
From a Technical Analysis Perspective, Is EVH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.